Guidelines and recommendations from various medical bodies, including the American Diabetes Association (ADA), European Society of Cardiology, and Diabetes Canada, have advocated for adding an SGLT2i following the use of a GLP-1RA, or vice versa, for T2DM patients with a high risk of developing ASCVD and those with CKD [68,69,70]
Gastrointestinal symptoms The most common side effects are gastrointestinal symptoms, such as nausea, vomiting, diarrhoea and constipation
Theres a class of type 2 diabetes drugs that not only improves blood sugar control but is best for weight loss
Emerging Research and Findings While the connection between GLP-1 therapy and improved sleep is promising, it's important to note that research in this area is still in its early stages